FDA DrugClass I

Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, LLC, NDC 63323-739-11 (unit of use), 63323-739-12 (unit of sale).

Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.

From the FDA notice · Read the official notice ↗ · All Fresenius Kabi recalls

What to do

The agency's notice has the remedy and who to contact.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, LLC, NDC 63323-739-11 (unit of use), 63323-739-12 (unit of sale).
Sold in
Nationwide
Made for
All ages (0 months and older)

Details

Units affected
2,199,850 vials
Illnesses reported
None reported
Manufactured in
3 Corporate Dr, N/A, Lake Zurich, IL, United States
Classification
Class I
Recall number
D-0182-2026

In the FDA's words

Description
Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, LLC, NDC 63323-739-11 (unit of use), 63323-739-12 (unit of sale). Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing. Lot #: 6133156, 6133194, Exp Date: 08/2026; 6133388, Exp Date: 10/2026. Distribution: Nationwide within the United States as well as AK, HI, and PR. Affected quantity: 2,199,850 vials
Hazard
Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.

More from Fresenius Kabi

See all

Related topics

SterilityDrugsSold nationwideMore from FDA Drug